Turnaround

The apparel conglomerate VF Corporation is showing initial signs of a potential turnaround, yet significant hurdles remain. Despite posting a...

While one segment of EMCOR's business is already delivering record-breaking performance, another appears poised for a significant rebound. The industrial...

Following its Chapter 11 restructuring, Wolfspeed appears to be charting a new course. The semiconductor manufacturer's recent unveiling of innovative...

Biotechnology firm Kezar Life Sciences is embarking on a fundamental strategic shift after encountering a significant regulatory obstacle. The U.S....

Travelzoo shares continue to face significant downward pressure, leaving investors questioning whether the decline has a foreseeable end. The company's...

Absci finds itself navigating turbulent financial waters as the biotechnology firm grapples with plunging revenue alongside aggressive investment in its...

While numerous biotechnology firms are scaling back expectations, Supernus Pharmaceuticals is projecting a surprisingly confident stance by reaffirming its annual...

Market experts are growing increasingly optimistic about defense technology specialist Mercury Systems, with Wall Street sentiment shifting decisively in the...

Biotechnology firm Equillium is executing a profound strategic overhaul, pivoting its entire operational focus to a single, promising drug candidate....

For Replimune and its investors, 2026 is shaping up to be a defining period. After a significant regulatory setback in...